Q&A With Theodore Lawrence, MD, PhD, on the Launch of the AACR Radiation Science and Medicine Working Group
Over 50 percent of all cancer patients will receive radiation therapy during the course of their treatments. This fact...
Category: AACR
Over 50 percent of all cancer patients will receive radiation therapy during the course of their treatments. This fact...
Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and...
We asked Eric Winer, MD, chief of the Division of Women's Cancers and director of the Breast Oncology Center...
Caregivers who are caring for loved ones with cancer may have more to worry about than managing their emotions....
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Guest Post by Roy S. Herbst, MD, PhD Yale Comprehensive Cancer Center
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...